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Is the demographic transition impacting on the perception of
degenerative musculoskeletal disease?
AGING PROCESS
The world is witnessing an unprece-
dented, irremediable, and longlasting
aging process.1 2 Table 1 provides popu-
lation decennial growth rates by 10 year
age groups and shows marked differ-
ences across age groups. Figures 1 and 2
display the projected population distri-
bution by 10 year age group. The graphs
evidence quite well the ‘‘baby boomers’’
wave that is going to extend continu-
ously the numbers of people over the
age of 60 years.
Western Europe should see the num-
bers of its inhabitants aged below 50
decrease dramatically, while those
above 60 should sharply increase. The
number of Europeans older than 60 is
projected to rise from 84 570 thousands
(21.8% of Europeans) at present to
107 592 thousands (32.8%) in 2050.
The increase is even more pronounced
for the old-old (80+) with the highest
growth rate (124.4%). Those aged 80+
would rise impressively from 14 610
thousands (3.8%) in 2000 up to 38 394
thousands (10.7%) in 2045 and then
stabilise. In North America, all age
groups should increase in number until
2050, but growth rates are notably
higher for those aged 60–69 (112.7%),
70–79 (104.3%) and, particularly, 80+
(234.3%). Whereas 50 876 thousands
(16.2% of northern Americans) people
were aged 60 in 2000, the number
would be 118 974 thousands (27.2%)
in 2050. Even faster than in Europe,
those aged 80 and above would drama-
tically increase from 10 094 thousands
(3.2%) in 2000 up to 33 743 thousands
(7.7%) in 2050.
‘‘The outstanding achievement of a
longer life span is now one of the
greater challenges for the current
century’’
Aging represents a major societal
progress characterising the continuous
and remarkable expansion of life span
over the past century. This outstanding
attainment is now one of the greater
challenges for the current century—that
is, ensuring the quality of life of an
unparalleled wide number of elderly
people.3 As these latter have been the
agents of that achievement, they must
also be its beneficiaries.
HEALTH AND QUALITY OF LIFE IN
THE ELDERLY
Health is the core of this challenge of
quality of life in later years. Modern
societies should be willing to afford the
elderly a blooming health to ensure that
they have every opportunity to remain
active and productive. In modern socie-
ties, most communicable diseases are
nowadays controlled or eradicated.
Apart from changes in medical technol-
ogy and individual factors, future
healthcare management and costs will
result from an increase in the prevalence
of age related chronic and disabling
conditions such as arthritis, which
belongs to the most prevalent age
related chronic conditions4–6 and which
has been consistently found to be a
leading cause of disability through wide
population health survey.7–9 The large
projected growth of the population aged
above 60 suggests a sharp increase in
the prevalence of arthritis for at least the
four forthcomings decades.
Concern surrounding future arthritis
prevalence is intensified when looking
at the demographic dynamic. Global
aging means that the increase in the
number of elderly people occurs con-
comitantly with relatively minor
changes (even decreases in Europe) in
the size of the younger population.
Dependency ratios (number of 60+/
number of 20–59) are expected to rise
dramatically between 2000 and 2045,
from 0.39 to 0.81 in Western Europe and
from 0.29 to 0.55 in Northern America.
The smaller proportion of people of
working age will have major social
implications for the supply of care and
support to the even greater number of
disabled people.10 11 Typically, formal
care for the disabled elderly is often
substantially complemented by informal
care and assistance provided by the
family such as children.12 13 With global
aging, those supporting their elders
would tend to be aged themselves (that
is, over 60 years old) and so, they would
be likely to develop arthritis and dis-
abilities as well. Moreover, arthritis has
been reported as an important cause of
days lost from work.14–16 If we look at the
Table 1 Population decennial growth rates by age groups from 2000 to 2050 (%)
Age groups
0–9 10–19 20–29 30–39 40–49 50–59 60–69 70–79 80+ Total
Western Europe
2000–2010 213.1 26.9 29.4 215.2 13.5 12.4 10.5 6.8 34.4 0.4
2010–2020 26.3 213.1 26.6 29.1 215.1 13.9 13.4 13.0 19.1 21.0
2020–2030 20.8 26.2 212.9 26.8 29.3 215.1 14.7 15.9 20.7 21.9
2030–2040 24.7 20.6 25.8 212.2 25.9 28.3 214.2 15.5 21.0 23.2
2040–2050 22.2 24.6 20.6 25.9 212.2 26.1 217.6 229.5 24.1 210.3
2000–2050 224.7 227.9 231.1 240.7 227.8 26.3 1.7 13.8 124.4 215.4
Northern America
2000–2010 25.4 5.9 13.7 28.4 2.3 35.7 42.7 1.3 23.5 8.8
2010–2020 7.5 25.3 5.3 12.5 28.0 2.7 36.8 46.8 11.7 8.2
2020–2030 6.0 7.1 24.9 5.1 12.3 27.5 3.5 38.9 45.9 7.1
2030–2040 4.8 5.7 6.7 24.5 5.1 12.4 26.7 4.4 45.2 5.5
2040–2050 6.3 4.6 5.4 6.4 24.3 5.2 12.9 25.2 14.4 4.7
2000–2050 20.0 18.8 28.2 10.0 6.3 52.5 112.7 104.3 234.3 39.3
Source: Population Division of the Department of Economic and Social Affairs of the United Nations.2 Western Europe: Euro zone countries, United Kingdom,
Sweden, Denmark, Norway and Switzerland; Northern America: USA and Canada.
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working segment of the population,
aging suggests that the size of the older
working population (that is 50–60
years) has increased as well. Societies
would be faced with an increasing
part of their labour force affected by
arthritis.
‘‘Global aging will mean that those
supporting their elders will be old
and, possibly arthritic, themselves’’
The socioeconomic burden attributa-
ble to arthritis is tremendous. Patients
report significant impairment in their
ability to perform activities of daily
living and in their quality of life.17 18
The psychosocial dimension is also
altered, with symptoms of depression
having been noticed.19 20 As a conse-
quence, arthritis results in towering
healthcare costs.21 22 Non-medical costs
are substantial as well.14–16 A thorough
and recent review from national studies
indicates that the economic costs of
arthritis represent 1.5–2.5% of the gross
national product (GNP), and total
healthcare expenditure among those
reporting arthritis approaches 3% of
the GNP.23
ARTHRITIS: A NEGLECTED HEALTH
PRIORITY
However, the importance of the burden
of arthritis on society remains under-
appreciated. Arthritis is too often viewed
as a normal and irremediable part of the
aging process. The ‘‘legitimacy’’ of
arthritis seems firmly rooted in general
opinion. Numerous patients believe that
nothing, or very little, can be done
against arthritis.24 25 Arthritis, and
musculoskeletal conditions in general,
remain low in national healthcare and
research priorities.26 In the United
States, a study investigating the rela-
tionship between funding by the
National Institute of Health and the
burden of diseases included neither
arthritis nor any other musculoskeletal
condition.27 A recent bibliometric study
showed that measured by literature
citation, musculoskeletal diseases
ranked ninth among 12 major Medline
disease categories in 1991 and 1996.28
Authors concluded that arthritis and
rheumatism are neglected health prio-
rities, receiving far less attention in the
scientific literature than is warranted by
their burden. These deductions emerge
despite the fact that several attempts
have been made to highlight arthritis as
an extending public health problem in a
demographic transition era since the
early nineties.10 29–32
In line with demographic changes
and in view of the poor awareness of
the burden of arthritis, the United
Nations, the World Health Organisa-
tion, and national governments have
launched, concomitantly with health
professionals and patient organisations,
the ‘‘Bone and Joint Decade’’ for the
years 2000–2010.33 34 This large world-
wide campaign aims at improving the
health related quality of life for people
with musculoskeletal conditions by
giving patients knowledge and infor-
mation and by advancing research on
prevention, diagnosis, and treatments.
There is growing evidence that we are
now better armed to reduce the impact
of arthritis. Risk factors for arthritis,
other than age and sex, have been
identified.4 35 Modifying the risk factors
may have direct preventive applica-
tions.35–37 As an example, interventions
such as weight control,38 39 promotion of
physical activity, and behavioural
changes39–44 have been shown to slow
the progression of arthritis. In addition,
early diagnosis45 46 and appropriate ther-
apeutic management47 48 may help to
improve the quality of life of arthritic
patients. As a last resort, joint arthro-
plasties are available to relieve pain and
return patients to better physical func-
tion.49 50 Recent reports emphasised the
underuse of hip and knee arthroplas-
ties51 and misperception about the nat-
ure of arthritis which may prevent
arthroplasty being carried out.52
It is important to change current
opinion on arthritis and to increase
knowledge of the possibilities available
at each level (prevention, therapeutics,
and education) for controlling symp-
toms, postponing disability, and giving
patients the ability to cope daily with
the disease. A lack of awareness about
effective interventions for arthritis
might have prevented both patients
and health professionals from imple-
menting effective intervention.25
Economic considerations and health
insurance policies cannot be ignored,
and health professionals should con-
tinue in their efforts to identify and
support cost effective actions.
Figure 1 Population distribution by 10 year age group in Western Europe from 2000 to 2050.2
Figure 2 Population distribution by 10 year age group in Northern America from 2000 to 2050.2
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